샘플 요청 목록

 카트 문의
시장보고서
상품코드
1771485

세계의 생명과학 툴 시장 규모, 점유율, 동향 분석 보고서 : 기술별, 제품 및 서비스별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Life Science Tools Market Size, Share & Trends Analysis Report By Technology, By Product & Service, By End-use, By Region, And Segment Forecasts, 2025 - 2030
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

생명과학 툴 시장 성장과 동향:

Grand View Research, Inc.의 최신 보고서에 따르면, 세계 생명과학 툴 시장 규모는 2025년부터 2030년까지 10.21%의 CAGR을 기록하여 2030년에는 2,995억 6,000만 달러에 달할 것으로 예상됩니다.

이러한 성장은 생명과학 기술에 대한 정부 자금의 증가, 세포 및 유전자 치료에 대한 수요, 바이오의약품의 채택 증가, 시장 내 유명 기업 간의 경쟁 심화에 기인합니다.

전 세계적으로 COVID-19 감염자가 급증함에 따라 감염 확산을 막기 위해 신속한 진단이 필요해졌고, 팬데믹 기간 동안 생명과학 툴에 대한 수요가 증가하여 시장에 긍정적인 영향을 미쳤습니다. 감염의 신속한 진단, 효과적인 치료 및 예방 계획은 COVID-19 팬데믹 기간 동안 사례 관리에 필수적입니다. 현재 SARS-CoV-2 감염을 확인하기 위한 비용 효율적인 접촉점 검사 키트와 효율적인 검사 방법의 개발 경쟁은 진단 기술 혁신의 새로운 지평을 주도하고 있습니다. 이번 팬데믹 기간 동안 미국 FDA는 일부 진단 검사에 긴급사용승인(EUA)을 부여하여 신속하고 쉽게 사용할 수 있도록 했습니다. 예를 들어, 2022년 5월 미국 FDA는 Abbott Diagnostics Scarborough의 신속 체외 진단 테스트인 ID NOW COVID-19 2.0에 EUA를 부여했습니다. 또한, 다양한 시판 중인 COVID-19 검사들이 시장에 출시되어 수익 창출에 더욱 기여할 수 있게 되었습니다.

또한, 생명과학 툴 산업은 연구 및 기술 발전을 위한 정부의 투자 증가를 바탕으로 성장하고 있으며, National Human Genome Research Institute(NHGRI), National Institutes of Health(NIH) 등의 기관은 다양한 생명과학 프로젝트에 적극적으로 자금을 지원하고 있습니다. 예를 들어, NIH는 핵 조직을 통해 유전자 조절과 세포 발현을 이해하는 것을 목표로 하는 '4D 뉴클레오름 프로그램'에 2,500만 달러의 자금을 지원하고 있습니다. 또한, 미국 정부는 연구개발 목적으로 여러 생명과학 기업에 자금을 지원하고 있습니다. 예를 들어, Biomedical Advanced Research and Development Authority(BARDA)는 의료 분야의 혁신적인 기술 개발을 촉진하기 위해 75만 달러 상당의 상을 수여할 계획입니다. 이처럼 기술뿐만 아니라 생명과학 연구에 대한 정부 자금의 증가는 향후 몇 년 동안 시장을 견인할 것으로 예상됩니다.

또한, 주요 기업들은 첨단 도구와 기술을 제공함으로써 시장 성장에 기여하고 있습니다. 또한, 각 회사는 새로운 자동화 솔루션을 시장에 출시하고 있으며, 이는 시장 성장에 유리한 기회를 제공하고 있습니다. 예를 들어, 2022년 2월 Covaris, LLC.는 필요한 모든 액세서리, 소모품, 시약으로 구성된 완전 자동화 워크플로우인 truXTRAC FFPE Total NA Auto 96 Kit의 출시를 발표했습니다. 이 자동화 키트는 Adaptive Focused Acoustics(AFA) 기술을 탑재하여 FFPE(포르말린 고정 파라핀 포매) 샘플에서 RNA와 DNA의 정제와 추출을 모두 5시간 내에 수행할 수 있습니다. 혁신적인 솔루션의 도입이 가까운 미래에 시장을 주도할 것으로 기대됩니다.

생명과학 툴 시장 : 분석 개요

  • 세포 생물학 기술 부문은 2024년 33.94%의 가장 큰 매출 점유율을 차지했습니다. 유전체 기술 시장 부문은 예측 기간 동안 가장 빠른 CAGR로 성장할 것으로 예상됩니다.
  • 세포배양 시스템 및 3D 세포배양 부문은 2024년 16.48%의 가장 큰 매출 점유율을 차지했습니다. 차세대 시퀀싱 부문은 예측 기간 동안 13.79%의 CAGR로 가장 빠르게 성장할 것으로 예상됩니다.
  • 의료 부문은 2024년 32.01%의 가장 큰 생명과학 시장 수익 점유율을 차지했습니다. 바이오의약품 부문은 예측 기간 동안 가장 빠르게 성장할 것으로 예상됩니다.
  • 북미는 2024년 44.69%의 가장 큰 매출 점유율을 차지하며 생명과학 툴 산업을 지배했습니다. 아시아태평양의 생명과학 툴 시장은 예측 기간 동안 크게 성장할 것으로 예상됩니다.

목차

제1장 분석 방법·범위

제2장 주요 요약

제3장 시장 변수, 동향, 범위

  • 시장 연관 전망
    • 상부 시장 전망
    • 관련/부수 시장 전망
  • 시장 역학
    • 시장 성장 촉진요인 분석
    • 시장 성장 억제요인 분석
  • 생명과학 툴 시장 : 분석 툴
    • 업계 분석 : Porter's Five Forces 분석
    • PESTEL 분석
    • 신종 코로나바이러스 감염증(COVID-19)의 영향 분석

제4장 생명과학 툴 시장 : 기술별 비즈니스 분석

  • 기술별 대시보드
  • 생명과학 툴 시장 : 기술별 변동 분석
  • 생명과학 툴 시장 : 시장 규모 예측과 동향 분석, 기술별(2018-2030년)
  • 유전체 기술
  • 단백질체학 기술
  • 세포생물학 기술
  • 실험 용품과 테크놀러지
  • 기타 분석·시료 조제 기술

제5장 생명과학 툴 시장 : 제품 및 서비스별 비즈니스 분석

  • 제품 및 서비스별 대시보드
  • 생명과학 툴 시장 : 제품 및 서비스별 변동 분석
  • 생명과학 툴 시장 : 시장 규모 예측과 동향 분석, 제품 및 서비스별(2018-2030년)
  • 세포배양 시스템과 3D 세포배양
  • 액체 크로마토그래피
  • 질량 분석
  • 유세포 분석
  • 클론 기술·유전체 공학
  • 현미경 검사·전자현미경 검사
  • 차세대 시퀀싱
  • PCR·qPCR
  • 핵산 조제
  • 핵산 마이크로어레이
  • 생어 시퀀싱
  • 트랜스펙션 장비·유전자 전달 기술
  • 핵자기공명
  • 기타 분리 기술
  • 기타 제품 및 서비스

제6장 생명과학 툴 시장 : 최종 용도별 비즈니스 분석

  • 최종 용도별 대시보드
  • 생명과학 툴 시장 : 최종 용도별 변동 분석
  • 생명과학 툴 시장 : 시장 규모 예측과 동향 분석, 최종 용도별(2018-2030년)
  • 정부·학술기관
  • 바이오의약품 기업
  • 의료
  • 산업 용도
  • 기타

제7장 생명과학 툴 시장 : 지역별 추정·동향 분석

  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 노르웨이
    • 스웨덴
    • 덴마크
    • 스위스
  • 아시아태평양
    • 일본
    • 중국
    • 인도
    • 싱가포르
    • 태국
    • 한국
    • 호주
  • 라틴아메리카
    • 브라질
    • 아르헨티나
  • 중동 및 아프리카
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트
    • 쿠웨이트

제8장 경쟁 구도

  • 기업 분류
  • 전략 매핑
  • 기업 시장 상황 분석(2024년)
  • 기업 개요/상장 기업
    • Agilent Technologies, Inc.
    • Becton, Dickinson, and Company
    • F. Hoffmann-La Roche Ltd.
    • Bio-Rad Laboratories, Inc.
    • Danaher Corporation
    • Illumina, Inc.
    • Thermo Fisher Scientific, Inc
    • QIAGEN NV
    • Merck KGaA
    • Shimadzu Corporation
    • Hitachi Ltd.
    • Bruker Corporation
    • Oxford Instruments plc
    • Zeiss International
ksm 25.07.24

Life Science Tools Market Growth & Trends:

The global life science tools market size is expected to reach USD 299.56 billion by 2030, registering a CAGR of 10.21% from 2025 to 2030, according to a new report by Grand View Research, Inc. This growth can be attributed to a rise in government funding for life science technologies, demand for cell and gene therapies, an increase in the adoption of biopharmaceuticals, and growing competition among prominent companies in the market.

The exponential rise of COVID-19 cases globally requires rapid diagnosis for containment of the spread of infectious disease, which boosted the demand for life science tools during the pandemic and had a positive impact on the market. Rapid diagnosis of the infection, effective treatments, and preventative plans are essential for the management of cases during the COVID-19 pandemic. The current race for the development of cost-effective point-of-contact test kits and efficient laboratory methodologies for confirmation of SARS-CoV-2 infection has driven a new frontier of diagnostic innovation. During this pandemic, the U.S. FDA granted Emergency Use Authorizations (EUAs) to several diagnostic tests to make them rapidly and easily available for use. For example, in May 2022, the U.S. FDA granted a EUA to ID NOW COVID-19 2.0, a rapid in-vitro diagnostic test by Abbott Diagnostics Scarborough, Inc. Moreover, a wide range of commercial COVID-19 tests is available in the marketplace, which will further add to revenue generation.

Additionally, the life science tools industry is expanding based on the increasing investments by the government for the advancement of research and technologies. Organizations such as The National Human Genome Research Institute (NHGRI) and the National Institutes of Health (NIH) are actively funding various life science projects. For instance, the NIH funded USD 25 million for the '4D Nucleome Program', which aims to understand gene regulation and cellular expression via the nuclear organization. Moreover, the U.S. government has funded several life sciences companies for R&D purposes. For instance, the Biomedical Advanced Research and Development Authority (BARDA) has planned to make awards worth USD 750,000 to facilitate the development of innovative technologies in the healthcare sector. Thus, the increase in government funding for life science research as well as technologies is expected to drive the market in the coming years.

Key players are also contributing to the growth of the market by providing advanced tools and techniques. Furthermore, companies are introducing new automated solutions in the market, which, in turn, provide lucrative opportunities for market growth. For instance, in February 2022, Covaris, LLC. announced the launch of truXTRAC FFPE Total NA Auto 96 Kit, a fully automated workflow comprising all necessary accessories, consumables, and reagents. This automated kit is powered by Adaptive Focused Acoustics (AFA) technology that allows both purification and extraction of RNA & DNA for FFPE (formalin fixed paraffin embedded) samples in 5 hours. The introduction of innovative solutions is expected to drive the market in the near future.

Life Science Tools Market Report Highlights:

  • The cell biology technology segment held the largest revenue share of 33.94% in 2024. The genomic technology market segment is expected to grow at the fastest CAGR over the forecast period.
  • The cell culture systems and 3D cell culture segment held the largest revenue share of 16.48% in 2024. The next-generation sequencing segment is expected to grow at the fastest CAGR of 13.79% over the forecast period.
  • The healthcare segment held the largest life science market revenue share of 32.01% in 2024. The biopharmaceutical segment is expected to grow fastest throughout the forecast period.
  • North America dominated the life science tools industry with the largest revenue share of 44.69% in 2024. The life science tools market in Asia Pacific is expected to grow significantly during the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Service Segment
    • 1.2.2. Technology Segment
    • 1.2.3. End Use Segment
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increased government funding for life science technologies
      • 3.2.1.2. Growth of cell and gene therapies
      • 3.2.1.3. Rise in the demand for biopharmaceuticals (biologics & biosimilars)
      • 3.2.1.4. Technological advancements in life science tools
      • 3.2.1.5. Applications of genomic and proteomic technologies for precision medicine
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost for some technologies
      • 3.2.2.2. Dearth of skilled professionals
  • 3.3. Life Science Tools Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Life Science Tools Market: Technology Business Analysis

  • 4.1. Technology Segment Dashboard
  • 4.2. Global Life Science Tools Market Technology Movement Analysis
  • 4.3. Global Life Science Tools Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 4.4. Genomic Technology
    • 4.4.1. Global Genomic Technology Market, 2018 - 2030 (USD Million)
  • 4.5. Proteomics Technology
    • 4.5.1. Global Proteomics Technology Market, 2018 - 2030 (USD Million)
  • 4.6. Cell Biology Technology
    • 4.6.1. Global Cell Biology Technology Market, 2018 - 2030 (USD Million)
  • 4.7. Lab Supplies & Technologies
    • 4.7.1. Global Lab Supplies & Technology Market, 2018 - 2030 (USD Million)
  • 4.8. Other Analytical & Sample Preparation Technology
    • 4.8.1. Global Other Analytical & Sample Preparation Technology Market, 2018 - 2030 (USD Million)

Chapter 5. Life Science Tools Market: Product & Service Business Analysis

  • 5.1. Product & Service Segment Dashboard
  • 5.2. Global Life Science Tools Market Product & Service Movement Analysis
  • 5.3. Global Life Science Tools Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
  • 5.4. Cell Culture Systems & 3D Cell Culture
    • 5.4.1. Global Cell Culture Systems & 3D Cell Culture Market, 2018 - 2030 (USD Million)
    • 5.4.2. Instruments
      • 5.4.2.1. Global Instruments Market, 2018 - 2030 (USD Million)
    • 5.4.3. Consumables
      • 5.4.3.1. Global Consumables Market, 2018 - 2030 (USD Million)
    • 5.4.4. Cell & Tissue Culture Services
      • 5.4.4.1. Global Cell & Tissue Culture Services Market, 2018 - 2030 (USD Million)
  • 5.5. Liquid Chromatography
    • 5.5.1. Global Liquid Chromatography Market, 2018 - 2030 (USD Million)
    • 5.5.2. Instruments
      • 5.5.2.1. Global Instruments Market, 2018 - 2030 (USD Million)
    • 5.5.3. Consumables
      • 5.5.3.1. Global Consumables Market, 2018 - 2030 (USD Million)
    • 5.5.4. Services
      • 5.5.4.1. Global Services Market, 2018 - 2030 (USD Million)
  • 5.6. Mass Spectrometry
    • 5.6.1. Global Mass Spectrometry Market, 2018 - 2030 (USD Million)
    • 5.6.2. Instruments
      • 5.6.2.1. Global Instruments Market, 2018 - 2030 (USD Million)
    • 5.6.3. Consumables
      • 5.6.3.1. Global Consumables Market, 2018 - 2030 (USD Million)
    • 5.6.4. Services
      • 5.6.4.1. Global Services Market, 2018 - 2030 (USD Million)
  • 5.7. Flow Cytometry
    • 5.7.1. Global Flow Cytometry Market, 2018 - 2030 (USD Million)
    • 5.7.2. Instruments
      • 5.7.2.1. Global Instruments Market, 2018 - 2030 (USD Million)
    • 5.7.3. Consumables
      • 5.7.3.1. Global Consumables Market, 2018 - 2030 (USD Million)
    • 5.7.4. Services
      • 5.7.4.1. Global Services Market, 2018 - 2030 (USD Million)
  • 5.8. Cloning & Genome Engineering
    • 5.8.1. Global Cloning & Genome Engineering Market, 2018 - 2030 (USD Million)
    • 5.8.2. Kits, Reagents, and Consumables
      • 5.8.2.1. Global Kits, Reagents, and Consumables Market, 2018 - 2030 (USD Million)
    • 5.8.3. Services
      • 5.8.3.1. Global Services Market, 2018 - 2030 (USD Million)
  • 5.9. Microscopy & Electron Microscopy
    • 5.9.1. Global Microscopy & Electron Microscopy Market, 2018 - 2030 (USD Million)
    • 5.9.2. Instruments
      • 5.9.2.1. Global Instruments Market, 2018 - 2030 (USD Million)
    • 5.9.3. Consumables
      • 5.9.3.1. Global Consumables Market, 2018 - 2030 (USD Million)
    • 5.9.4. Services
      • 5.9.4.1. Global Services Market, 2018 - 2030 (USD Million)
  • 5.10. Next Generation Sequencing
    • 5.10.1. Global Next Generation Sequencing Market, 2018 - 2030 (USD Million)
    • 5.10.2. Instruments
      • 5.10.2.1. Global Instruments Market, 2018 - 2030 (USD Million)
    • 5.10.3. Consumables
      • 5.10.3.1. Global Consumables Market, 2018 - 2030 (USD Million)
    • 5.10.4. Services
      • 5.10.4.1. Global Services Market, 2018 - 2030 (USD Million)
  • 5.11. PCR & qPCR
    • 5.11.1. Global PCR & qPCR Market, 2018 - 2030 (USD Million)
    • 5.11.2. Instruments
      • 5.11.2.1. Global Instruments Market, 2018 - 2030 (USD Million)
    • 5.11.3. Consumables
      • 5.11.3.1. Global Consumables Market, 2018 - 2030 (USD Million)
    • 5.11.4. Services
      • 5.11.4.1. Global Services Market, 2018 - 2030 (USD Million)
  • 5.12. Nucleic Acid Preparation
    • 5.12.1. Global Nucleic Acid Preparation Market, 2018 - 2030 (USD Million)
    • 5.12.2. Instruments
      • 5.12.2.1. Global Instruments Market, 2018 - 2030 (USD Million)
    • 5.12.3. Consumables
      • 5.12.3.1. Global Consumables Market, 2018 - 2030 (USD Million)
    • 5.12.4. Services
      • 5.12.4.1. Global Services Market, 2018 - 2030 (USD Million)
  • 5.13. Nucleic Acid Microarray
    • 5.13.1. Global Nucleic Acid Microarray Market, 2018 - 2030 (USD Million)
    • 5.13.2. Instruments
      • 5.13.2.1. Global Instruments Market, 2018 - 2030 (USD Million)
    • 5.13.3. Consumables
      • 5.13.3.1. Global Consumables Market, 2018 - 2030 (USD Million)
    • 5.13.4. Services
      • 5.13.4.1. Global Services Market, 2018 - 2030 (USD Million)
  • 5.14. Sanger Sequencing
    • 5.14.1. Global Sanger Sequencing Market, 2018 - 2030 (USD Million)
    • 5.14.2. Instruments
      • 5.14.2.1. Global Instruments Market, 2018 - 2030 (USD Million)
    • 5.14.3. Consumables
      • 5.14.3.1. Global Consumables Market, 2018 - 2030 (USD Million)
    • 5.14.4. Services
      • 5.14.4.1. Global Services Market, 2018 - 2030 (USD Million)
  • 5.15. Transfection Devices & Gene Delivery Technologies
    • 5.15.1. Global Transfection Devices & Gene Delivery Technologies Market, 2018 - 2030 (USD Million)
    • 5.15.2. Equipment
      • 5.15.2.1. Global Equipment Market, 2018 - 2030 (USD Million)
    • 5.15.3. Reagents
      • 5.15.3.1. Global Reagents Market, 2018 - 2030 (USD Million)
  • 5.16. NMR
    • 5.16.1. Global NMR Market, 2018 - 2030 (USD Million)
    • 5.16.2. Instruments
      • 5.16.2.1. Global Instruments Market, 2018 - 2030 (USD Million)
    • 5.16.3. Consumables
      • 5.16.3.1. Global Consumables Market, 2018 - 2030 (USD Million)
    • 5.16.4. Services
      • 5.16.4.1. Global Services Market, 2018 - 2030 (USD Million)
  • 5.17. Other Separation Technologies
    • 5.17.1. Global Other Separation Technologies Market, 2018 - 2030 (USD Million)
    • 5.17.2. Instruments
      • 5.17.2.1. Global Instruments Market, 2018 - 2030 (USD Million)
    • 5.17.3. Consumables
      • 5.17.3.1. Global Consumables Market, 2018 - 2030 (USD Million)
    • 5.17.4. Services
      • 5.17.4.1. Global Services Market, 2018 - 2030 (USD Million)
  • 5.18. Other Products & Services
    • 5.18.1. Global Other Products & Services Market, 2018 - 2030 (USD Million)
    • 5.18.2. Antibodies
      • 5.18.2.1. Global Antibodies Market, 2018 - 2030 (USD Million)
    • 5.18.3. General Supplies
      • 5.18.3.1. Global General Supplies Market, 2018 - 2030 (USD Million)
    • 5.18.4. Others
      • 5.18.4.1. Global Others Market, 2018 - 2030 (USD Million)
      • 5.18.4.2. Instruments
        • 5.18.4.2.1. Global Instruments Market, 2018 - 2030 (USD Million)
      • 5.18.4.3. Consumables
        • 5.18.4.3.1. Global Consumables Market, 2018 - 2030 (USD Million)
      • 5.18.4.4. Services
        • 5.18.4.4.1. Global Services Market, 2018 - 2030 (USD Million)

Chapter 6. Life Science Tools Market: End Use Business Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Global Life Science Tools Market End Use Movement Analysis
  • 6.3. Global Life Science Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Government & Academic
    • 6.4.1. Global Government & Academic Devices Market, 2018 - 2030 (USD Million)
  • 6.5. Biopharmaceutical Companies
      • 6.5.1.1. Global Biopharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • 6.6. Healthcare
      • 6.6.1.1. Global Healthcare Market, 2018 - 2030 (USD Million)
  • 6.7. Industrial Applications
    • 6.7.1. Global Industrial Applications Market, 2018 - 2030 (USD Million)
  • 6.8. Others
    • 6.8.1. Global Others Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Life Science Tools Market: Region Estimates & Trend Analysis

  • 7.1. North America
    • 7.1.1. North America market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.1.2. U.S.
      • 7.1.2.1. Key country dynamics
      • 7.1.2.2. Competitive scenario
      • 7.1.2.3. Regulatory Framework
      • 7.1.2.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.1.3. Canada
      • 7.1.3.1. Key country dynamics
      • 7.1.3.2. Competitive scenario
      • 7.1.3.3. Regulatory Framework
      • 7.1.3.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.1.4. Mexico
      • 7.1.4.1. Key country dynamics
      • 7.1.4.2. Competitive scenario
      • 7.1.4.3. Regulatory Framework
      • 7.1.4.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.2. Europe
    • 7.2.1. Europe market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.2.2. UK
      • 7.2.2.1. Key country dynamics
      • 7.2.2.2. Competitive scenario
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.2.3. Germany
      • 7.2.3.1. Key country dynamics
      • 7.2.3.2. Competitive scenario
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.2.4. France
      • 7.2.4.1. Key country dynamics
      • 7.2.4.2. Competitive scenario
      • 7.2.4.3. Regulatory Framework
      • 7.2.4.4. France market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.2.5. Italy
      • 7.2.5.1. Key country dynamics
      • 7.2.5.2. Competitive scenario
      • 7.2.5.3. Regulatory Framework
      • 7.2.5.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.2.6. Spain
      • 7.2.6.1. Key country dynamics
      • 7.2.6.2. Competitive scenario
      • 7.2.6.3. Regulatory Framework
      • 7.2.6.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.2.7. Norway
      • 7.2.7.1. Key country dynamics
      • 7.2.7.2. Competitive scenario
      • 7.2.7.3. Regulatory Framework
      • 7.2.7.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.2.8. Sweden
      • 7.2.8.1. Key country dynamics
      • 7.2.8.2. Competitive scenario
      • 7.2.8.3. Regulatory Framework
      • 7.2.8.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.2.9. Denmark
      • 7.2.9.1. Key country dynamics
      • 7.2.9.2. Competitive scenario
      • 7.2.9.3. Regulatory Framework
      • 7.2.9.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.2.10. Switzerland
      • 7.2.10.1. Key country dynamics
      • 7.2.10.2. Competitive scenario
      • 7.2.10.3. Regulatory Framework
      • 7.2.10.4. Switzerland market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.3. Asia Pacific
    • 7.3.1. Asia Pacific market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.3.2. Japan
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Competitive scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.3.3. China
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Competitive scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. China market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.3.4. India
      • 7.3.4.1. Key country dynamics
      • 7.3.4.2. Competitive scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. India market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.3.5. Singapore
      • 7.3.5.1. Key country dynamics
      • 7.3.5.2. Competitive scenario
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Singapore market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.3.6. Thailand
      • 7.3.6.1. Key country dynamics
      • 7.3.6.2. Competitive scenario
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.3.7. South Korea
      • 7.3.7.1. Key country dynamics
      • 7.3.7.2. Competitive scenario
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.3.8. Australia
      • 7.3.8.1. Key country dynamics
      • 7.3.8.2. Competitive scenario
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.4. Latin America
    • 7.4.1. Latin America market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.2. Brazil
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Competitive scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.3. Argentina
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Competitive scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.5. Middle East & Africa
    • 7.5.1. Middle East & Africa market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.2. South Africa
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.3. Saudi Arabia
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.4. UAE
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Competitive scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.5. Kuwait
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Competitive scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. Agilent Technologies, Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product & Services Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Becton, Dickinson, and Company
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product & Services Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. F. Hoffmann-La Roche Ltd.
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product & Services Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Bio-Rad Laboratories, Inc.
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product & Services Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Danaher Corporation
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product & Services Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Illumina, Inc.
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product & Services Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Thermo Fisher Scientific, Inc
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product & Services Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. QIAGEN N.V.
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product & Services Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Merck KGaA
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product & Services Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Shimadzu Corporation
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product & Services Benchmarking
      • 8.4.10.4. Strategic Initiatives
    • 8.4.11. Hitachi Ltd.
      • 8.4.11.1. Overview
      • 8.4.11.2. Financial Performance
      • 8.4.11.3. Product & Services Benchmarking
      • 8.4.11.4. Strategic Initiatives
    • 8.4.12. Bruker Corporation
      • 8.4.12.1. Overview
      • 8.4.12.2. Financial Performance
      • 8.4.12.3. Product & Services Benchmarking
      • 8.4.12.4. Strategic Initiatives
    • 8.4.13. Oxford Instruments plc
      • 8.4.13.1. Overview
      • 8.4.13.2. Financial Performance
      • 8.4.13.3. Product & Services Benchmarking
      • 8.4.13.4. Strategic Initiatives
    • 8.4.14. Zeiss International
      • 8.4.14.1. Overview
      • 8.4.14.2. Financial Performance
      • 8.4.14.3. Product & Services Benchmarking
      • 8.4.14.4. Strategic Initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제